Strain Name | B6/JGpt-Apoeem1Cd82/Gpt | Application |
1.Cardiovascular disease research |
Strain Type | knockout CRISPR/Cas9 | ||
Strain ID | T001458 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | B6/JGpt-Ldlrem1Cd82/Gpt | Application |
1.Cardiovascular disease research |
Strain Type | knockout CRISPR/Cas9 | ||
Strain ID | T001464 | ||
Backgrounde | C57BLKS/JNju |
Strain Name | BKS-Leprem2Cd479/Gpt | Application |
1. Study of Diabetes Type2 |
Strain Type | knockout CRISPR/Cas9 | ||
Strain ID | T002407 | ||
Backgrounde | C57BLKS/JNju |
Strain Name | B6/JGpt-Lepem1Cd25/Gpt | Application |
1. Study of obesity |
Strain Type | knockout CRISPR/Cas9 | ||
Strain ID | T001461 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | C57BL/6JGpt DIO 60% | Application |
1. Diet induced Obesity model |
Strain Type | Inbred | ||
Strain ID | T002040 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | BALB/cJGpt-Foxn1nu/Gpt | Application |
1. Dermatologic study2. Endocrine deficiency research |
Strain Type | Mutation | ||
Strain ID | D000521 | ||
Backgrounde | BALB/cJGpt |
Strain Name | NOD/ShiLtJGpt-Prkdcem26Cd52/Gpt | Application |
1. Type I Diabetes, Obesity research2. Immune, Inflammatory study |
Strain Type | Cas9-KO | ||
Strain ID | T001492 | ||
Backgrounde | NOD/ShiLtJGpt |
Strain Name | NOD/ShiLtJGpt-Prkdcem26Cd52Il2rgem26Cd22/Gpt | Application |
1. Human innune system reconstitution2. Preclinical anti-tumor efficacy study with CDX,PDX |
Strain Type | Knock-out | ||
Strain ID | T001475 | ||
Backgrounde | NOD/ShiLtJGpt |
Strain Name | NOD/ShiLtJGpt-Prkdcem26Cd52Il2rgem26Cd22Hrem1Cin8936/Gpt | Application |
1. Research of humanized mouse models2. CDX, PDX |
Strain Type | knock-in | ||
Strain ID | T003257 | ||
Backgrounde | NOD/ShiLtJGpt |
Strain Name | NOD/ShiLtJGpt-B2Mem21Cd4Prkdcem26Cd52Il2rgem26Cd22/Gpt | Application |
1. Human immune system reconstitution2. Human tumor transplantation |
Strain Type | knock-out | ||
Strain ID | T004670 | ||
Backgrounde | NOD/ShiLtJGpt |
Strain Name | BALB/cJGpt-Cd274em1Cin(hCD274)/Gpt | Application |
1. Efficacy evaluation of human PDL1 inhibitors |
Strain Type | knock-in CRISPR/Cas9 | ||
Strain ID | T003260 | ||
Backgrounde | BALB/cJGpt |
Strain Name | B6/JGpt-Cd274tm1(hCD274)/Gpt | Application |
1. Efficacy evaluation of human PDL1 inhibitors |
Strain Type | knock-in ES | ||
Strain ID | T003455 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | BALB/cJGpt-Pdcd1em1Cin(hPDCD1)/ Gpt | Application |
1. Efficacy evaluation of human PD1 inhibitors |
Strain Type | knock-in CRISPR/Cas9 | ||
Strain ID | T002726 | ||
Backgrounde | BALB/cJGpt |
Strain Name | BALB/cJGpt-Pdcd1 em1Cin(hPDCD1) Tigit em1Cin(hTIGIT) /Gpt | Application |
1. Screening of human TIGIT inhibitors or human PD1 inhibitors |
Strain Type | Knock-in | ||
Strain ID | T004023 | ||
Backgrounde | BALB/cJGpt |
Strain Name | B6/JGpt-Pdcd1 em1Cin(hPDCD1) Tigit em1Cin(hTIGIT) /Gpt | Application |
1. Screening of human TIGIT inhibitors or human PD1 inhibitors |
Strain Type | Knock-in | ||
Strain ID | T004024 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | BALB/cJGpt-Tigit em1Cin(hTIGIT) /Gpt | Application |
1. Efficacy evaluation of human TIGIT inhibitors |
Strain Type | Knock-in | ||
Strain ID | T003365 | ||
Backgrounde | BALB/cJGpt |
Strain Name | BALB/cJGpt -Ctla4 em1Cin(hCTLA4) /Gpt | Application |
1. Efficacy evaluation of human CTLA4 inhibitor |
Strain Type | Knock-in | ||
Strain ID | T003361 | ||
Backgrounde | BALB/cJGpt |
Strain Name | B6/JGpt-Pdcd1 em1Cin(hPDCD1) Ctla4 em1Cin(hCTLA4) /Gpt | Application |
1. Efficacy evaluation of human CTLA4,PD1 inhibitor |
Strain Type | Knock-in | ||
Strain ID | T003826 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | BALB/cJGpt -Ctla4 em1Cin(hCTLA4) /Gpt | Application |
1. Efficacy evaluation of human CTLA4 inhibitor |
Strain Type | Knock-in | ||
Strain ID | T003361 | ||
Backgrounde | BALB/cJGpt |
Strain Name | BALB/cJGpt-Tnfrsf9 em1Cin(hTNFRSF9) /Gpt | Application |
1. Efficacy evaluation of human CD137 agonist |
Strain Type | Knock-in | ||
Strain ID | T003359 | ||
Backgrounde | BALB/cJGpt |
Strain Name | BALB/cJGpt-Pdcd1 em1Cin(hPDCD1) Tnfrsf4 em1Cin(hTNFRSF4) /Gpt | Application |
1. Screening of human OX40 agonists or human PD1 inhibitors |
Strain Type | Knock-in | ||
Strain ID | T003804 | ||
Backgrounde | BALB/cJGpt |
Strain Name | B6/JGpt-Pdcd1 em1Cin(hPDCD1) Lag3 emCin(hLAG3) /Gpt | Application |
1. Evaluation of efficacy and safety of human LAG3 inhibitors |
Strain Type | Knock-in | ||
Strain ID | T004621 | ||
Backgrounde | C57BL/6JGpt |
Strain Name | BALB/cJGpt- Pdcd1 em1Cin(hPDCD1) Havcr2 tm1(hHAVCR2) / Gpt | Application |
1. Efficacy evaluation of human TIM3 inhibitor |
Strain Type | Knock-in | ||
Strain ID | T004795 | ||
Backgrounde | BALB/cJGpt |
CRISPR/Cas9 is the most common gene editiong technology currently which can be used to establish gene-edited mice including CKO/KO/KI/PM. | |
Advantages |
|
ES Homologous Recombination(HR) Technology for obtaining gene-edited mouse models is more suitable for establishing mouse models with complex editing | |
Advantages |
|
Obtained Genetic engineering mouse models by random integration of DNA into the mouse genome is generally used for the establishment of overexpressed or conditioned overexpressed mice. | |
Advantages |
|